Medicine
ONSWIK KwikPen 500 IU/mL injection
ONSWIK KwikPen 500 IU/mL injection is a prescription medicine containing Insulin efsitora alfa for subcutaneous use, marketed by Eli Lilly, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store ONSWIK refrigerated at 2°C to 8°C (36°F to 46°F) at all times. If…
Key facts
- Active ingredient (INN)
- Insulin efsitora alfa
- Brand
- ONSWIK KwikPen
- Strength
- 500 IU/mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe
- Marketing authorisation holder
- Eli Lilly
- Manufacturer
- Eli Lilly
- Origin register
- US FDA, United States
- Storage
- Store ONSWIK refrigerated at 2°C to 8°C (36°F to 46°F) at all times. If refrigeration is unavailable, the pen can be stored at room temperature up to 30°C (86°F) for up to a total of 14 days. Do not freeze ONSWIK. Dispose of ONSWIK that has been left at room temperature for longer than 14 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.31Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 September 2026
- Identifiers
- RxCUI 2754149, 2754156, 2754159 +1DailyMed set ID 6e02229e-262c-4e25-9240-9e9de4eb7c1dNDC 0002-5137Application BLA761408
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 carton / 3 mL in 1 syringe | 0002-5137-11 | Eli Lilly | 23 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 September 2026 | Drugs@FDA |
| EU (EMA) | Opinion | EMA medicines data |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Insulin efsitora alfa
Clinical summary
Insulin efsitora alfa is a prescription medicine indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as injection for subcutaneous use. MedsAcross supplies Insulin efsitora alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Insulin efsitora alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ONSWIK KwikPen prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
Need ONSWIK KwikPen 500 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.